finerenone

Fri, 22 Apr 2022 13:03:22 -0400
Finerenone is indicated to delay progression of kidney disease and to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke) and hospitalization for heart failure in adults with chronic kidney disease (CKD) and type 2 diabetes (T2D).